CLINICAL_TRIALS
withdrawal
· 2025-03-21
Clinical Trial Update: Predict to Prevent PGRN Disease [NA]
Summary
A clinical trial investigating GRN-related frontotemporal dementia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Frontotemporal Dementia (FTD), GRN Related Frontotemporal Dementia | NA | Status: WITHDRAWN